|
LOC729603 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.88578058618805E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64157576421076E-12 |
| Normal-vs-Stage2 |
3.822900E-03 |
| Normal-vs-Stage3 |
5.21559999633325E-08 |
| Normal-vs-Stage4 |
5.75259999635591E-08 |
| Stage1-vs-Stage2 |
9.571800E-04 |
| Stage1-vs-Stage3 |
3.234600E-01 |
| Stage1-vs-Stage4 |
5.045600E-01 |
| Stage2-vs-Stage3 |
3.891800E-02 |
| Stage2-vs-Stage4 |
2.595800E-03 |
| Stage3-vs-Stage4 |
1.671820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
2.432500E-04 |
| Normal-vs-Asian |
1.13280000046956E-07 |
| Caucasian-vs-AfricanAmerican |
9.405400E-01 |
| Caucasian-vs-Asian |
3.609600E-02 |
| AfricanAmerican-vs-Asian |
1.151630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.75059991345006E-10 |
| Normal-vs-Female |
1.69164682262135E-12 |
| Male-vs-Female |
4.515400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04758432431618E-12 |
| Normal-vs-Age(41-60Yrs) |
1.54519730344305E-11 |
| Normal-vs-Age(61-80Yrs) |
1.58809999999399E-05 |
| Normal-vs-Age(81-100Yrs) |
1.974630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.546200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.762700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.434800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.650100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.741600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.444400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.519000E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
5.249000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
7.9080999970671E-08 |
| Tall-VS-Other |
6.027200E-01 |
| Tall-VS-Normal |
4.6177994761365E-10 |
| Follicular-VS-Other |
2.004500E-02 |
| Follicular-VS-Normal |
2.575000E-01 |
| Other-VS-Normal |
7.110400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36169999720437E-08 |
| Normal-vs-N1 |
9.12529996011102E-09 |
| N0-vs-N1 |
6.423000E-04 |
|
|
